Skip to Content

Active Growth Portfolio

For those seeking an active approach to investing in large cap ASX stocks

About the Active Growth Portfolio

About The Portfolio

The Market Matters Active Growth Portfolio provides an active exposure to Australian large-cap shares, aiming for reduced volatility. Returns will be achieved through a combination of capital appreciation and income with an overall objective of outperformance of the S&P/ASX 200 Accumulation Index over the medium term (3 years).

Portfolio Performance
Portfolio 1m 3m 6m 1y 3y pa ITD pa*
ACTIVE GROWTH 5.82% 7.50% 15.46% 20.96% 15.43% 14.91%
ASX 200 ACCUMULATION 3.27% 5.33% 14.17% 14.45% 9.62% 9.48%
VALUE ADD +2.55% +2.17% +1.29% +6.51% +5.81% +5.43%
* Inception date 10/05/2016
Portfolio Holdings trade now
COMPANY CODE STOCK NAME WEIGHT (%) RISK TIME HORIZON ENTRY DATE ENTRY PRICE ($) LAST PRICE ($) DIVIDENDS ($) DAILY CHANGE (%) GAIN / LOSS (%)
ANZ ANZ Bank 6 Moderate Long 08/02/2023 25.29 28.46 2.29 0.32 21.59
BHP BHP Group 8 Moderate Long 27/08/2019 39.51 45.17 12.38 1.64 45.66
CTD Corporate Travel Mgmt 4 Moderate Medium 6/03/2024 16.46 15.94 1.05 -3.16
EVN Evolution Mining 4 Moderate Medium 1/12/2022 2.94 4.04 0.08 -2.88 40.14
GMG Goodman Group 4 High Medium 24/10/2023 21.15 30.49 0.15 -2.56 44.87
ILU Iluka Resources 4 High Medium 07/02/2024 7.20 7.42 0.06 2.49 3.89
MFG Magellan 4 High Medium 6/03/2024 9.15 8.97 -0.66 -1.97
MIN Mineral Resources 5 High Medium 16/03/2023 73.73 70.01 0.80 0.89 -3.96
NAB National Australia Bank 6 Moderate Medium 15/12/2022 30.33 33.46 2.39 0.94 18.20
NSR National Storage REIT 5 Moderate Medium 11/08/2023 2.22 2.22 0.06 0.45 2.70
PLS Pilbara Minerals 4 High Medium 18/01/2024 3.48 3.89 1.17 11.78
RHC Ramsay Healthcare 5 Moderate Long 12/04/2023 68.86 50.55 0.36 -1.04 -26.07
RMD Resmed 5 Moderate Medium 28/10/2021 33.23 27.86 0.39 -3.53 -14.99
SFR Sandfire Resources 4 High Medium 18/05/2023 5.87 9.14 1.50 55.71
S32 South32 4 Moderate Medium 05/04/2024 3.19 3.28 0.92 2.82
TWE Treasury Wine Estates 5 High Medium 20/04/2023 13.60 11.92 0.66 -0.46 -7.50
WHC Whitehaven Coal 4 High Medium 15/11/2022 8.18 7.88 1.16 1.03 10.51
WOR Worley 4 High Medium 08/05/2023 15.85 16.50 0.50 1.04 7.26
XRO Xero 5 Moderate Long 02/04/2020 101.29 119.51 0.67 17.99
Portfolio cash position: 10%
Recent Sales trade now
Company code STOCK NAME WEIGHT(%) RISK TIME HORIZON EXIT DATE ENTRY PRICE ($) CLOSE PRICE ($) DIVIDENDS ($) GAIN / LOSS (%)
EVN Evolution Mining 1 Moderate Medium 5/04/2024 2.94 3.85 0.016 31.5
PDN Paladin Energy 4 High Medium 5/04/2024 1.18 1.42 20.33
ORA Orora 5 Moderate Medium 3/04/2024 2.8 2.24 0.05 -18.21
LLC Lendlease 5 High Medium 6/03/2024 7.2 6.18 -14.14
ALU Altium 5 High Medium 31/01/2024 42.53 49.27 15.85
MQG Macquarie Group 6 Moderate Medium 31/01/2024 177.99 189.41 13.29 13.88
NST Northern Star 5 High Medium 18/01/2024 11.14 12.16 0.16 10.59
PDN Paladin 3 High Medium 15/01/2024 0.83 1.31 57.83
MFG Magellan Financial Group 4 High Medium 08/01/2024 9.22 9.09 0.93 8.68
WDS Woodside 4 Moderate Medium 24/10/2023 35.66 35.23 1.78 3.79
CWY Cleanaway Waste Management 5 High Medium 05/10/2023 2.69 2.34 0.02 -12.27
NCM Newcrest Mining 5 Moderate Medium 25/08/2023 29.35 25.42 2.52 -4.8
ELD Elders 3 High Medium 25/08/2023 7.11 6.47 -9
SEK Seek 3 High Medium 17/08/2023 24.29 23.35 0.34 -2.47
GMG GMG 5 Moderate Medium 11/08/2023 23.43 20.17 0.3 -12.63
ILU Iluka 5 Moderate Medium 21/06/2023 10.74 11.66 0.64 14.53
JHX James Hardie 4 High Medium 21/06/2023 31.2 39.89 27.85
CSL CSL Limited 4 Moderate Medium 15/06/2023 260.92 279.41 3.82 8.55
JHX James Hardie 1 High Medium 26/05/2023 31.2 37.83 21.25
XRO Xero 2 High Long 22/05/2023 92.85 108.79 17.16
WDS Woodside 3 Moderate Medium 08/05/2023 30.23 34.05 5.28 30.1
IGO Independence Group 3 Moderate Medium 28/04/2023 10.66 13.61 0.27 30.21
SFR Sandfire Resources 3 High Medium 20/04/2023 4.1 6.93 69.02
CSL CSL Ltd 2 Moderate Medium 20/04/2023 260.92 300.94 3.82 16.8
REA REA Group 2 High Medium 20/04/2023 120.42 140.69 1.07 17.72
ALU Altium 5 High Medium 12/04/2023 28.8 37.65 1.08 34.48
CBA Commonwealth Bank 5 Moderate Long 08/02/2023 59.88 110.4 11.9 104.24
SEK Seek 5 Moderate Medium 03/02/2023 19.86 25.55 28.65
MQG Macquarie Group 2 Moderate Medium 03/02/2023 178.3 190.89 6.34 10.61
SFR Sandfire Resources 1.07 High Medium 18/01/2023 4.1 6.15 50
HUB HUB24 4 Moderate Medium 09/01/2023 22.79 27.66 0.37 22.99
SFR Sandfire Resources 1.5 High Medium 08/12/2022 4.07 5.38 32.18
more

Opinions for stocks held in the Growth Portfolio

Iluka Resources Ltd (ILU) $7.24

ILU has been in the mineral sands business for many years, but now it has added a major rare earth string to its bow via its Eneabba rare earth refinery project. After a challenging 2023, the mineral sands industry appears to have stabilised, with sentiment improving in most areas. We believe downgrades have gone too far, which could see the stock rapidly “pop” ~10%.

Read more

Whitehaven Coal Ltd (WHC) $7.80

Coal miner WHC rallied +2% on Wednesday, making a new 10-week high in the process. We have been almost stubbornly bullish on WHC over the last year, but its fortunes are turning, and a test of its 2024 high is starting to feel like a matter of time. Remember last week, influential broker UBS significantly upgraded the miner, increasing their price target from $6.30 to $8.70; it's not often you see an almost 40% upgrade without left-field news.

Read more

Evolution Mining (EVN) $4.16

EVN +7.49%: the gold & copper miner hit near 2-year highs today on the back of a 3Q update that was better than feared. They produced 185koz of gold in the quarter, up 15% from 2Q where they faced a few production issues including wet weather. The company also produced 20kt of copper, up ~30% which helped their net gold All In Sustaining Cost (AISC) number fall to $1,464/oz.

Read more

ResMed (RMD) versus CSL Ltd (CSL)

The Australian Healthcare is trading at a ~70% premium to the ASX 200 on a 1-year forward PE, which is close to its recent normal; hence, we are considering switching with the sector as opposed to outright buying or selling. RMD & CSL are two very different healthcare businesses, although both suffered in 2023 at the hands of Ozempic et al.. In both cases, the sell-off was over-blown in our opinion, but that’s the nature of stocks when the crowd runs as one.

Read more

South32 Ltd (S32) $3.44

On Monday, S32 was the second-best performer in the ASX200, surging +4.6% following higher base metal prices. MM has been watching S32 carefully through its decline, looking for an optimum entry-level; we finally pressed the “Buy Button” earlier this month, already sitting on an ~8% gain. If we are correct and China’s economy is basing, and the global economy will continue to prove resilient, S32 will be very well positioned moving through 2024/5.

Read more

Xero Ltd (XRO) $121.80

MM remains a big fan of this online cloud-based accounting software company XRO, but after more than doubling from its 2022 low, we are closer to trimming than adding to our 5% position. However, this is a quality company, and we have no plans to sell into weakness; in line with our ”three steps forward, two back” outlook, we may trim into strength, but we are likely to be fussy.

Read more

Iluka Resources Ltd (ILU) $7.44

ILU is one of a few “quasi-plays” on the Chinese economy, which has slowly started to show signs of stabilisation after a very tough few years. We believe its $6-8 trading range is likely to prevail for most of 2024; hence, we may tweak our position accordingly.

Read more

Goodman Group (GMG) $32.07

GMG reversed ~80% of its early losses on Thursday to end the session down just 0.8%, a very impressive performance considering the US Retail Sector fell -4.1%. Also, NEXTDC (NXT), another alternative for exposure to data centres, albeit very different, launched a significant $1.3bn capital raise. We continue to believe this $61bn business is the number one stock in the Australian Property Sector and will remain a core holding for us until further notice.

Read more

ResMed Inc (RMD) $29.56

RMD rallied +1.5% in a falling market on Thursday, an encouraging move for the sleep disorder business, which has been on a wild Ozempic ride over the last year – unfortunately, overnight trade in the US suggests it will struggle this morning. At MM, we’ve commented on many of RMD’s twists and turns through its volatile journey since many of us first heard about miracle slimming drugs, and after its 43% recovery, the risk/reward is diminishing fast for the bulls.

Read more
more

Actions for stocks held in the Growth Portfolio

ILU
UPDATED 18/04/2024 09:01
MM is long and bullish towards ILU in the short term
Add To Hit List
WHC
UPDATED 18/04/2024 08:58
MM remains long and bullish towards WHC
Add To Hit List
RMD
UPDATED 17/04/2024 16:57
MM is considering switching RMD into CSL in the Active Growth Portfolio
Add To Hit List
EVN
UPDATED 17/04/2024 16:56
MM is long and bullish EVN
Add To Hit List
S32
UPDATED 16/04/2024 09:48
MM remains long and bullish toward S32
Add To Hit List
RMD
UPDATED 12/04/2024 09:58
MM is cautiously bullish toward RMD short-term
Add To Hit List
GMG
UPDATED 12/04/2024 09:57
MM remains bullish towards GMG medium-term
Add To Hit List
ILU
UPDATED 12/04/2024 09:57
MM is long and bullish ILU short/medium term
Add To Hit List
XRO
UPDATED 12/04/2024 09:54
MM remains long and bullish toward XRO
Add To Hit List
MFG
UPDATED 12/04/2024 09:53
MM are buying MFG in the Active Income Portfolio, initiating with a 4% weighting around $9.30
Add To Hit List
more
scroll
Back to top